Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement
Street Talk

Greencross rejects $740 million takeover bid from TPG

Edited by Sarah Thompson, Anthony Macdonald and Joyce Moullakis

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Greencross has rejected a $740 million takeover bid from private equity giant TPG, sources said.

Street Talk can reveal that TPG made an indicative bid for Greencross a couple of days before Christmas, offering to pay about $6.45 a share for all shares in the veterinary group and pet retailer it did not already own.

The offer was pitched at a 39 per cent premium to Greencross' trading price as at December 14 - the day before TPG had investment bank Credit Suisse launch a raid to buy a 14.99 per cent stake in the company at $5.79 a share.

Pet retailer and veterinary group Greencross Ltd is under fire from private equity.  Bruce Mercer

However, it is understood Greencross formally knocked back the takeover bid earlier this month.

Greencross, advised by Macquarie Capital, Allier Capital and Clayton Utz, also opted not to disclose the approach to shareholders.

Advertisement

The bid comes as Greencross is widely expected to launch an auction for the company, inviting the likes of TPG and its rivals to make bids. However, sources said there had been little real evidence that Greencross was preparing for such a process.

It has also come at a convenient time for the group, with its shares trading higher despite market volatility in late December and January. Given the challenging equity market conditions - and the fact a lot of fund managers' portfolios would be down for the financial year and calendar year-to-date, you would have to think Greencross' board and advisers would be under some pressure to engage with interested parties.

TPG's interest has underpinned Greencross' share price. The private equity firm has had Credit Suisse in the market buying shares at up to $6.45 each, according to a substantial shareholder notice filed in late December, and is sitting on a 6.9 per cent stake.

Interestingly, Credit Suisse isn't the most active broker in the market this year. Goldman Sachs bought $23 million of stock, worth about 3 per cent of the company, in the first three weeks of the new year.

Sources have questioned whether Goldman Sachs is buying on behalf of New Zealand's EBOS Group. As Street Talk revealed in December, EBOS met with Greencross chairman Stuart Bruce James as it considers its options.

Greencross shares are certainly trading like there will be a deal. The stock last closed at $6.81 - well above the $4.63 a share level when TPG made its first public move.

Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
Joyce Moullakis wrote on banking and finance, specialising in Investment Banking, Private Equity, Financial Services. Connect with Joyce on Twitter. Email Joyce at jmoullakis@afr.com.au

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More